6bR,10aS)-3-methyl-8-nitroso-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxaline

N-Nitroso Lumateperone is an impurity present in Lumateperone, lumateperone acts as a potent serotonin 5-HT2A receptor antagonist, dopamine D2 receptor presynaptic partial agonist and postsynaptic antagonist, D1 receptor-dependent modulator of glutamate, and serotonin reuptake inhibitor, which is used for the short-term treatment of schizophrenia.

Additional information on 4 | 5]pyrrolo[1 | 2 | 3-de]quinoxaline

Catalogue No.

VE009760

CAS No.

N/A

Molecular Formula

C14H18N4O

Molecular Weight

258.32 g/mol

Parent drug

Lumateperone

IUPAC Name

(6bR, 10aS)-3-methyl-8-nitroso-2, 3, 6b, 7, 8, 9, 10, 10a-octahydro-1H-pyrido[3', 4':4, 5]pyrrolo[1, 2, 3-de]quinoxaline

Synonyms

N/A

References

Edinoff, A., Wu, N., deBoisblanc, C., Feltner, C. O., Norder, M., Tzoneva, V., … Urits, I. (2020). Lumateperone for the Treatment of Schizophrenia. Psychopharmacology Bulletin, 50(4), 32–59. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511146/

Status

In-stock